UTI Asset Management Company or AMC is the largest asset management company in India in terms of Total AUM and the seventh-largest possession management business in India in terms of the mutual fund. Incorporated in 2002, UTI AMC remains in business of handling the domestic mutual funds of UTI Mutual Fund, provides portfolio management services to institutional customers and high net worth people like Employee Provident Fund Organisation, National Skill Development Fund, Postal Life Insurance, and handles retirement funds viz. NPS, overseas funds like Shinsei UTI India Fund, and alternative financial investment funds accommodating a varied group of people, institutional financiers, banks, trusts, and NRIs. The short article is about UTI Asset Management Company IPO Review.
UTI AMC FAQs
What is the lot size of UTI AMC IPO?
UTI AMC IPO lot size and the minimum order amount is not readily available at this time. Please examine once again later.
When UTI AMC IPO will open?
The UTI AMC IPO dates are not announced. Please check back once again after some time.
What is UTI AMC IPO?
UTI AMC IPO is essentially a main-board IPO of 38,987,081 equity shares of the face value of 10 aggregating as much as 3,000.00 Crores.KFin Technologies Private Limited is the registrar for the IPO. The shares are proposed to be noted on BSE, NSE.
How to get UTI AMC IPO?
ASBA IPO application is readily available in the net banking of your bank account. UPI IPO application is offered by brokers who do not use banking services.
UTI Asset Management Company Issue Details
UTI AMC IPO details
Overall IPO size
According to CRISIL, UTI AMC is the largest AMC in India in terms of Total AUM, seventh-largest AMC in India in terms of mutual fund QAAUM with 1,542.3 billion, and also has the biggest share of regular monthly typical AUM amongst leading 10 Indian AMC coming from B30 cities.
The management costs from domestic shared funds account for 72.7% of the total income of the company.
UTI AMC has developed the first mutual fund in India and has actually remained in the asset management market for more than 55 years with a strong history and proven performance history in shared fund mutual industry with strong brand acknowledgment.
UTI AMC has 11 million live folios accounting for 12.8% of client base handled by the Indian shared fund market.
The company has a national footprint with 163 UTI Financial Centres, 273 Business Development Associates, and Chief Agents, and 33 other Official Points of Acceptance. It also has around 51,000 Independent Financial Advisors.
UTI AMC has 4 sponsors SBI, LIC, PNB, and BOB each of which has the Government of India as a bulk investor. UTI AMC likewise has an international possession management company T. Rowe Price International Ltd as one of its significant stakeholders with a 26% stake in the Company.
As of September 30, 2019, UTI AMC handles 178 domestic mutual fund schemes, consisting of equity, hybrid, money, liquid, and earnings market funds.
About the Company.
To be upgraded
The items of the Offer are:.
INR10 per share.
Things of the Issue:.
To be updated
Minimum quote (lot size).
To be upgraded.
1. To attain the benefits of listing the Equity Shares on the Stock Exchanges and2. The sale of approximately 38,987,081 Equity Shares by the Selling Shareholders.
For the year/period ended (in Million).
Profit After Tax.
UTI Asset Management Company IPO Review.
ASBA IPO application is offered in the net banking of your bank account. UPI IPO application is provided by brokers who do not use banking services.
The UTI asset management businesss IPO review will be out after releasing the concern details.
UTI Asset Management Company or AMC is the biggest asset management company in India in terms of Total AUM and the seventh-largest property management company in India in terms of the shared fund. NPS, offshore funds like Shinsei UTI India Fund, and alternative financial investment funds catering to a varied group of people, institutional investors, banks, trusts, and NRIs. The short article is about UTI Asset Management Company IPO Review.